Iberdomide (Zenbexus)

Iberdomide (Zenbexus) is an oral medication being studied to treat blood cancers, particularly multiple myeloma. It belongs to a class of drugs called CELMoDs, which work by helping your own immune system recognize and break down abnormal cancer cells. This space provides information on how the medication is taken, its potential side effects, and where it fits into current clinical trials and treatment plans. You can also connect with other patients and caregivers to share experiences, ask questions, and learn practical tips for managing daily life while taking this therapy.